Cargando…
Accelerating the research, development, and acquisition of medical countermeasures against biological warfare agents : interim report /
Having the means to protect its military personnel against biological warfare agents is a long-standing objective for the United States. The development of safe and effective medical countermeasures -- vaccines, antitoxins, and prophylactic and therapeutic drugs -- against those agents is one of the...
| Clasificación: | Libro Electrónico |
|---|---|
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
The National Academies Press,
[2003]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocm58596199 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||||| | ||
| 008 | 140806s2003 dcu ob 000 0 eng | ||
| 040 | |a NLM |b eng |e rda |e pn |c NLM |d N$T |d YDXCP |d IDEBK |d NTE |d VAM |d GAO |d ZMC |d ADU |d E7B |d DKDLA |d CPC |d FVL |d UCNAP |d AU@ |d COO |d NLGGC |d DEBSZ |d OCLCQ |d OCLCO |d AZK |d OCLCQ |d AGLDB |d MOR |d IQW |d PIFBR |d OCLCQ |d U3W |d BUF |d STF |d WRM |d OCLCQ |d VTS |d COCUF |d NRAMU |d OCLCQ |d TKN |d G3B |d OCLCQ |d OCLCO |d K6U |d OCLCA |d NLM |d OCLCO |d OCLCA |d OCLCO |d OCLCQ |d QGK | ||
| 016 | 7 | |a 101644185 |2 DNLM | |
| 019 | |a 52081374 |a 474421167 |a 481901331 |a 614936410 |a 646728116 |a 654543550 |a 722334299 |a 728012300 |a 814297143 |a 817890245 |a 842259809 |a 870329010 |a 888694415 |a 961672569 |a 962599475 |a 1259258316 | ||
| 020 | |a 0309582598 | ||
| 020 | |a 9780309582599 | ||
| 020 | |a 1280247843 | ||
| 020 | |a 9781280247842 | ||
| 029 | 0 | |a NLM |b 101644185 | |
| 029 | 1 | |a AU@ |b 000050893646 | |
| 029 | 1 | |a AU@ |b 000051451225 | |
| 029 | 1 | |a AU@ |b 000052938978 | |
| 029 | 1 | |a AU@ |b 000053243324 | |
| 029 | 1 | |a DEBBG |b BV043034939 | |
| 029 | 1 | |a DEBSZ |b 422348198 | |
| 029 | 1 | |a GBVCP |b 801267358 | |
| 029 | 1 | |a NZ1 |b 12047053 | |
| 035 | |a (OCoLC)58596199 |z (OCoLC)52081374 |z (OCoLC)474421167 |z (OCoLC)481901331 |z (OCoLC)614936410 |z (OCoLC)646728116 |z (OCoLC)654543550 |z (OCoLC)722334299 |z (OCoLC)728012300 |z (OCoLC)814297143 |z (OCoLC)817890245 |z (OCoLC)842259809 |z (OCoLC)870329010 |z (OCoLC)888694415 |z (OCoLC)961672569 |z (OCoLC)962599475 |z (OCoLC)1259258316 | ||
| 037 | |b 00017961 | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA648 |b .C66 2003eb | |
| 060 | 0 | 0 | |a WA 295 |
| 072 | 7 | |a MED |x 096000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.9 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Accelerating the research, development, and acquisition of medical countermeasures against biological warfare agents : |b interim report / |c Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences, Institute of Medicine, and National Research Council of the National Academies. |
| 264 | 1 | |a Washington, DC : |b The National Academies Press, |c [2003] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 500 | |a Title from title screen. | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | |a Having the means to protect its military personnel against biological warfare agents is a long-standing objective for the United States. The development of safe and effective medical countermeasures -- vaccines, antitoxins, and prophylactic and therapeutic drugs -- against those agents is one of the essential components of the nation's biological defense efforts. Currently, the United States has a limited repertoire of licensed medical countermeasures that the Department of Defense (DoD) can use to protect members of the armed forces against more than a dozen bacteria, viruses, and toxins identified as possible biological warfare agents. As part of its Chemical and Biological Defense Program, DoD is engaged in research and development efforts aimed at making available a broader range of medical countermeasures. | ||
| 588 | 0 | |a Version viewed January 9, 2015. | |
| 505 | 0 | |a Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents -- Copyright -- Reviewers -- Contents -- INTRODUCTION -- STUDY COMMITTEE AND STUDY CHARGE -- STUDY PROCESS -- STATUS OF THE COMMITTEE'S INVESTIGATIONS -- REFERENCES -- Appendix Agendas for Information-Gathering Meetings. | |
| 546 | |a English. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 610 | 1 | 2 | |a United States |b Department of Defense |
| 650 | 0 | |a Biological weapons |x Health aspects. | |
| 650 | 7 | |a MEDICAL |x Toxicology. |2 bisacsh | |
| 650 | 7 | |a Toxicology. |2 fast |0 (OCoLC)fst01153364 | |
| 650 | 1 | 2 | |a Biological Warfare Agents |
| 650 | 1 | 2 | |a Biological Warfare |x prevention & control |
| 650 | 2 | 2 | |a Military Medicine |x methods |
| 650 | 2 | 2 | |a Civil Defense |x methods |
| 651 | 2 | |a United States | |
| 710 | 2 | |a Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, |e issuing body. | |
| 776 | |z 0-309-58259-8 | ||
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=123486 |z Texto completo |
| 938 | |a ebrary |b EBRY |n ebr10071987 | ||
| 938 | |a EBSCOhost |b EBSC |n 123486 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 24784 | ||
| 938 | |a YBP Library Services |b YANK |n 2294024 | ||
| 994 | |a 92 |b IZTAP | ||